TORONTO, March 04, 2024 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device […]
SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational […]
New data advances understanding of new approaches to treating Alzheimer’s disease Research on disease progression could help inform future clinical […]